BIOMAT Database Logo BIOMAT Database Logo

Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers. 1995

E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Institute of Pharmacological Sciences, University of Milan, Italy.

This study addressed two questions: 1) whether a relatively low dose of n-3 fatty acid ethyl esters (n-3 FAs) administered to healthy volunteers for a prolonged period of time would exert beneficial effects on plasma lipids, platelet function, and thromboxane biosynthesis; and 2) whether a short-term loading treatment (6 wk) with 6 g n-3 FAs/d followed by 12 wk with 3 g/d results in more pronounced effects. After 6 wk treatment a reduction of plasma triglyceride concentration and an accumulation of EPA and DHA in plasma were observed. A longer period of treatment with n-3 FAs was necessary to affect platelet aggregation and thromboxane A2 biosynthesis. At 12 and 18 wk, platelet aggregation, thromboxane A2 formation, and the excretion of thromboxane metabolites in urine were reduced, particularly in subjects who received 6 g n-3 FAs/d during the initial 6 wk. After treatment ended, triglyceride and thromboxane A2 biosynthesis returned to baseline values within 4 wk, whereas platelet aggregation remained impaired for > or = 14 wk. The longlasting impairment in platelet aggregation was accompanied by the retention of n-3 FAs in platelet phospholipids.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane

Related Publications

E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Effect of n-3 fatty acid ethyl ester supplementation on fatty acid composition of the single platelet phospholipids and on platelet functions.
May 1995, Metabolism: clinical and experimental,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation.
February 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Fatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregation.
January 2006, Journal of thrombosis and haemostasis : JTH,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Platelet effects of omega 3 fatty acid ethyl esters.
January 1994, World review of nutrition and dietetics,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Effects of prolonged ingestion of graded doses of licorice by healthy volunteers.
January 1994, Life sciences,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Fatty acid ethyl ester formation by plasma in vitro.
February 1966, Canadian journal of biochemistry,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Fatty acid ethyl ester synthesis by human liver microsomes.
January 1996, Biochimica et biophysica acta,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs.
June 2001, Biochemistry. Biokhimiia,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Platelet aggregation on whole blood after administration of ultra low dosage acetylsalicylic acid in healthy volunteers.
August 1987, Thrombosis research,
E Tremoli, and P Maderna, and F Marangoni, and S Colli, and S Eligini, and I Catalano, and M T Angeli, and F Pazzucconi, and G Gianfranceschi, and G Davi
Persistent impairment of platelet aggregation following cessation of a short-course dietary supplementation of moderate amounts of N-3 fatty acid ethyl esters.
July 1999, Thrombosis and haemostasis,
Copied contents to your clipboard!